Traws Gross Profit from 2010 to 2025

TRAW Stock

7.17 0.00 0.00%

Traws Pharma Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 179.6 K in 2025. Gross Profit is the profit Traws Pharma makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

189 K

Current Value

179.6 K

Quarterly Volatility

988.8 K

Credit Downgrade

Yuan Drop

Covid

Check Traws Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Traws Pharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 15.6 K or Total Revenue of 193.2 K, as well as many indicators such as Price To Sales Ratio of 1.1 K, Dividend Yield of 0.0 or PTB Ratio of 30.16. Traws financial statements analysis is a perfect complement when working with Traws Pharma Valuation or Volatility modules.

Check out the analysis of Traws Pharma Correlation against competitors.

For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

Latest Traws Pharma's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Traws Pharma over the last few years. Gross profit is a required income statement account that reflects total revenue of Traws Pharma minus its cost of goods sold. It is profit before Traws Pharma operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Traws Pharma's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Traws Pharma's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Traws Gross Profit Regression Statistics

	Arithmetic Mean	1,441,472
	Geometric Mean	898,940
	Coefficient Of Variation	68.59
	Mean Deviation	926,910
	Median	2,183,000
	Standard Deviation	988,761
	Sample Variance	977.6B
	Range	2M
	R-Value	(0.84)
	Mean Square Error	304.1B
	R-Squared	0.71
	Significance	0.000042
	Slope	(174,960)
	Total Sum of Squares	14.7T

Traws Gross Profit History

	2025	179.6 K
	2024	189 K
	2023	210 K
	2021	212 K
	2020	231 K

Other Fundumenentals of Traws Pharma

Gross Profit Margin

Traws Pharma Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Net Invested Capital	Capital Stock	Net Working Capital
Total Assets		1.0	-0.21	-0.91	-0.49	-0.54	-0.51	-0.82	1.0	-0.5	0.98	0.6	0.98
Total Stockholder Equity	1.0		-0.15	-0.93	-0.46	-0.58	-0.47	-0.81	1.0	-0.46	0.98	0.56	0.98
Current Deferred Revenue	-0.21	-0.15		-0.22	0.38	-0.4	0.54	0.63	-0.21	0.41	-0.13	-0.55	-0.11
Net Debt	-0.91	-0.93	-0.22		0.31	0.71	0.28	0.55	-0.91	0.32	-0.92	-0.36	-0.93
Retained Earnings	-0.49	-0.46	0.38	0.31		-0.24	0.92	0.48	-0.49	0.88	-0.58	-0.85	-0.56
Accounts Payable	-0.54	-0.58	-0.4	0.71	-0.24		-0.34	0.19	-0.54	-0.29	-0.49	0.33	-0.52
Net Receivables	-0.51	-0.47	0.54	0.28	0.92	-0.34		0.53	-0.52	0.98	-0.59	-0.9	-0.57
Total Liab	-0.82	-0.81	0.63	0.55	0.48	0.19	0.53		-0.83	0.42	-0.75	-0.72	-0.74
Total Current Assets	1.0	1.0	-0.21	-0.91	-0.49	-0.54	-0.52	-0.83		-0.51	0.98	0.6	0.98
Common Stock	-0.5	-0.46	0.41	0.32	0.88	-0.29	0.98	0.42	-0.51		-0.6	-0.83	-0.58
Net Invested Capital	0.98	0.98	-0.13	-0.92	-0.58	-0.49	-0.59	-0.75	0.98	-0.6		0.64	1.0
Capital Stock	0.6	0.56	-0.55	-0.36	-0.85	0.33	-0.9	-0.72	0.6	-0.83	0.64		0.62
Net Working Capital	0.98	0.98	-0.11	-0.93	-0.56	-0.52	-0.57	-0.74	0.98	-0.58	1.0	0.62

Click cells to compare fundamentals

About Traws Pharma Financial Statements

Traws Pharma investors use historical fundamental indicators, such as Traws Pharma's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Traws Pharma. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	189 K	179.6 K
Gross Profit Margin	1.07	1.03

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

EBR	Centrais Electricas Brasileiras
HE	Hawaiian Electric Industries
VFC	VF Corporation

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC